Published in Br J Cancer on June 01, 1989
Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br J Cancer (2005) 1.31
Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest (1993) 1.30
Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4. Br J Cancer (1991) 0.95
Tumour-associated upregulation of the IL-4 receptor complex. Br J Cancer Suppl (1990) 0.92
Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins. Immunology (1991) 0.91
Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer. Br J Cancer (1992) 0.83
Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124). Br J Cancer (1996) 0.81
Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast. Br J Cancer (1996) 0.79
Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance. Br J Cancer (1996) 0.75
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (1984) 17.70
Cellular oncogenes and retroviruses. Annu Rev Biochem (1983) 10.65
Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med (1982) 9.49
Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci U S A (1986) 6.16
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci U S A (1987) 3.64
T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc Natl Acad Sci U S A (1986) 3.56
Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science (1984) 3.06
B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J Exp Med (1987) 2.09
Characterization of the human B cell stimulatory factor 1 receptor. J Exp Med (1987) 1.92
Oncogenes in development. Development (1987) 1.86
Radioactive labeling of antibody: a simple and efficient method. Science (1983) 1.83
B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines. J Exp Med (1986) 1.82
Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. Lancet (1982) 1.71
The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies. Immunology (1985) 1.56
Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer (1986) 1.45
Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest (1983) 1.42
Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood (1983) 1.39
Epidermal growth factor receptors in lung tumours. J Pathol (1987) 1.36
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res (1987) 1.18
Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol (1987) 1.18
Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor. Immunology (1988) 1.12
Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J (Clin Res Ed) (1985) 1.11
Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res (1987) 1.07
A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment. Immunology (1988) 1.02
Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today (1996) 3.80
Tissue interaction in the development of thymus lymphocytes. J Exp Med (1969) 2.95
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet (1982) 2.51
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet (2002) 2.38
The thymic microenvironment. Immunol Today (1993) 2.36
Total knee arthroplasty after high tibial osteotomy. A comparison study in patients who had bilateral total knee replacement. J Bone Joint Surg Am (2000) 2.06
A monoclonal antibody that detects HLA-D region antigen in routinely fixed, wax embedded sections of normal and neoplastic lymphoid tissues. J Clin Pathol (1985) 2.00
Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med (1990) 1.76
Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet (1982) 1.76
Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am (1977) 1.65
High-LET radiations induce a large proportion of non-rejoining DNA breaks. Nature (1977) 1.64
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies. Immunology (1985) 1.56
OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy (2014) 1.54
Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood (1983) 1.54
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys (2000) 1.54
The true function of the thymus? Immunol Today (1989) 1.50
Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med (1999) 1.48
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Exp Hematol (1996) 1.47
Polyethylene wear in cemented metal-backed acetabular cups. J Bone Joint Surg Br (1993) 1.46
The biomechanical and biochemical properties of swine tendons--long term effects of exercise on the digital extensors. Connect Tissue Res (1980) 1.46
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol (1987) 1.42
The human thymus microenvironment: in vivo identification of thymic nurse cells and other antigenically-distinct subpopulations of epithelial cells. Immunology (1981) 1.42
Predictive range of motion after total knee replacement. Clin Orthop Relat Res (1979) 1.40
Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res (1986) 1.39
Alternative to toxicity and dosimetry of Y-90 labeled antibody. Int J Radiat Oncol Biol Phys (1989) 1.39
Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamster-to-rat cardiac xenograft. Transplantation (1999) 1.38
Surface antigen differentiation during human myogenesis in culture. Nature (1981) 1.34
Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J Exp Med (1988) 1.34
Effect of range of motion on the success of a total knee arthroplasty. J Arthroplasty (1987) 1.32
Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res (1998) 1.25
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer (1995) 1.25
Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res (1986) 1.24
The extensor indicis proprius syndrome. J Bone Joint Surg Am (1969) 1.23
The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am (1996) 1.23
Dislocation and subluxation of the total hip replacement. Clin Orthop Relat Res (1977) 1.22
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy (2011) 1.20
Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy (2006) 1.19
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. Br J Cancer (1984) 1.19
Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol (1987) 1.18
Structures at risk from medially placed acetabular screws. J Bone Joint Surg Am (1990) 1.18
Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in in the detection of neoplasms of testis, ovary, and cervix. Lancet (1985) 1.17
Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells. J Bone Joint Surg Am (1991) 1.16
A study of in vivo immune complex formation and clearance in man. J Immunol (1990) 1.14
Negative ultrasound findings in patients with cervical artery dissection. Negative ultrasound in CAD. J Neurol (2005) 1.13
Congenital dislocation of the hip in the newborn. Am J Dis Child (1973) 1.13
Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J Nucl Med (1989) 1.13
Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor. Immunology (1988) 1.12
Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy (2005) 1.12
Thymic epithelial antibodies: immunohistological analysis and introduction of nomenclature. Thymus (1989) 1.11
Systemic effects of polymethylmethacrylate. Increased serum levels of gamma-glutamyltranspeptidase following arthroplasty. Acta Orthop Scand (1984) 1.11
Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int J Cancer (1990) 1.11
Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J (Clin Res Ed) (1985) 1.11
The operating room environment as affected by people and the surgical face mask. Clin Orthop Relat Res (1975) 1.10
Association of thy-1 cell surface differentiation antigen with certain connective tissues in vivo. Cell Tissue Res (1980) 1.10
Microbiological studies in a horizontal wall-less laminar air-flow operating room during actual surgery. Clin Orthop Relat Res (1974) 1.10
Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol Immunol (2004) 1.10
Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol (2001) 1.09
Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol (1994) 1.08
The natural history of a posteriorly dislocated total hip replacement. J Arthroplasty (1999) 1.08
Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res (1987) 1.07
Development of anti-idiotypic antibodies against tumour antigens and autoantigens in ovarian cancer patients treated intraperitoneally with mouse monoclonal antibodies. Lancet (1988) 1.07
Distribution of identity of Thy-1-bearing cells during ontogeny in rat hemopoietic and lymphoid tissues. J Immunol (1978) 1.06
Hypotension associated with methyl methacrylate in total hip arthroplasties. Clin Orthop Relat Res (1972) 1.06
The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty. Clin Orthop Relat Res (1982) 1.06
Intramedullary versus extramedullary femoral alignment systems in total knee replacement. Clin Orthop Relat Res (1993) 1.05
Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest (1994) 1.05
The effects of exercise on the biomechanical and biochemical properties of swine digital flexor tendons. J Biomech Eng (1981) 1.04
Antibody guided lymphangiography in the staging of cervical cancer. Br J Cancer (1985) 1.04
Human Thy-1 antigen: cell surface expression on early T and B lymphocytes. Immunology (1983) 1.02
Impaction bone-grafting before insertion of a femoral stem with cement in revision total hip arthroplasty. A minimum two-year follow-up study. J Bone Joint Surg Am (1997) 1.02
A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment. Immunology (1988) 1.02
B-cell precursors in early chicken embryos. Immunology (1979) 1.01
The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy (2005) 1.01
Lumbar spondylolysis and spondylolisthesis in college football players. A prospective study. Am J Sports Med (1986) 1.01
A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest (1996) 1.00
Arterial hypertension and ischaemic stroke. Acta Neurol Scand (2003) 0.99
IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin Immunol (1997) 0.99
Total knee arthroplasty after high tibial osteotomy. Clin Orthop Relat Res (2000) 0.98
Intraperitoneal 131I- and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry. Int J Cancer Suppl (1988) 0.98
Interleukin 4 receptor expression on human lung tumors and normal lung. Cancer Res (1991) 0.97
Site-specific polysialylation of an antitumor single-chain Fv fragment. Bioconjug Chem (2009) 0.97
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer (1993) 0.97
Tibial torsion? Clin Orthop Relat Res (1976) 0.96
Human Thy-1: expression on the cell surface of neuronal and glial cells. Brain Res (1982) 0.96
Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells. Cancer Res (2000) 0.96
Direct visualization of thymocyte apoptosis in neglect, acute and steady-state negative selection. Int Immunol (1996) 0.95
Comparison of the midvastus muscle-splitting approach with the median parapatellar approach in total knee arthroplasty. J Arthroplasty (1999) 0.95
Immunohistology of the thymus in bone marrow transplant recipients. Am J Pathol (1986) 0.95
Use of lateral heel and sole wedges in the treatment of medial osteoarthritis of the knee. Orthop Rev (1993) 0.95